Stay informed with the latest litigation news. Explore now

IP Verse

Glaxo Group competitive analysis

Latest publications and patents of Glaxo Group New

Explore the latest publications and patents granted to Glaxo Group, showcasing their recent innovations and technological advancements.

Last updated on: Sep 9, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Glaxo Group

EP3578169
Jun 26, 2024Pharmaceutical Formulations Comprising 4-{(1 R)-2-[(6-{2-[(2,6-Dichlorobenzyl)Oxy]Ethoxy}Hexyl)Amino]-1-Hydroxyethyl}-2-(Hydroxymethyl)PhenolGranted And Under Opposition
EP3335707
Apr 17, 2024Combinations Of A Muscarinic Receptor Antagonist And A Beta-2 Adrenoreceptor AgonistGranted And Under Opposition
EP1907037
Sep 7, 2022Medicament DispenserPatent Maintained As Amended
EP2005372
May 18, 2022Counter For Use With A Medicament DispenserRevoked
EP3199164
Mar 18, 2020Processes For Making Lactose Utilizing Pre-Classification Techniques And Pharmaceutical Formulations Formed TherefromOpposition Rejected
EP2400950
May 22, 2019Pharmaceutical Formulations Comprising 4-{(1R)-2- [(6-{2-[(2,6-Dichlorobenzyl)Oxy] Ethoxy}Hexyl)Amino]-1-Hydroxyethyl}-2- (Hydroxymethyl)PhenolGranted And Under Opposition
EP2162231
Jan 10, 2018Fluid DispenserNo Opposition Filed Within Time Limit
EP2506844
Dec 20, 2017Combinations Of A Muscarinic Receptor Antagonist And A Beta-2 Adrenoreceptor AgonistOpposition Rejected
EP2512491
Oct 11, 2017Hbv Antisense InhibitorsRevoked
EP7819116
Oct 26, 2010Medicament Dispenser -

Latest oppositions filed by Glaxo Group

Explore patent oppositions filed by Glaxo Group against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 11, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3459578
Dispensing DevicePFIZERDec 2, 2021
EP3057612
Method Of Obtaining Thermostable Dried Vaccine FormulationsMERCK SHARP & DOHMEFeb 5, 2021
EP2266549
Method Of Making Particles For Use In A Pharmaceutical CompositionVECTURAMay 6, 2020
EP2298279
Pharmaceutical Compositions For InhalationVECTURAAug 12, 2019
EP2752216
Dispensing DevicePFIZERJul 19, 2019
EP2708558
Antigen-Binding Molecule Capable Of Binding To Two Or More Antigen Molecules RepeatedlyCHUGAI SEIYAKU KABUSHIKI KAISHADec 18, 2018
EP2708559
Antigen-Binding Molecule Capable Of Binding To Two Or More Antigen Molecules RepeatedlyCHUGAI SEIYAKU KABUSHIKI KAISHADec 18, 2018
EP2188371
Use Of Perfusion To Enhance Production Of Fed-Batch Cell Culture In BioreactorsWYETHSep 20, 2018
EP2586788
Prevention Of Disulfide Bond Reduction During Recombinant Production Of PolypeptidesGENENTECHAug 27, 2018
EP2283818
Method Of Making Particles For Use In A Pharmaceutical CompositionVECTURAMay 1, 2018

Latest patents of Glaxo Group opposed by its competitors

Explore Glaxo Group's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 11, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3578169
Jun 26, 2024Pharmaceutical Formulations Comprising 4-{(1 R)-2-[(6-{2-[(2,6-Dichlorobenzyl)Oxy]Ethoxy}Hexyl)Amino]-1-Hydroxyethyl}-2-(Hydroxymethyl)Phenol1
EP3335707
Apr 17, 2024Combinations Of A Muscarinic Receptor Antagonist And A Beta-2 Adrenoreceptor Agonist5
EP1907037
Sep 7, 2022Medicament Dispenser1
EP2005372
May 18, 2022Counter For Use With A Medicament Dispenser1
EP3199164
Mar 18, 2020Processes For Making Lactose Utilizing Pre-Classification Techniques And Pharmaceutical Formulations Formed Therefrom1
EP2400950
May 22, 2019Pharmaceutical Formulations Comprising 4-{(1R)-2- [(6-{2-[(2,6-Dichlorobenzyl)Oxy] Ethoxy}Hexyl)Amino]-1-Hydroxyethyl}-2- (Hydroxymethyl)Phenol8
EP2506844
Dec 20, 2017Combinations Of A Muscarinic Receptor Antagonist And A Beta-2 Adrenoreceptor Agonist3
EP2512491
Oct 11, 2017Hbv Antisense Inhibitors1

Latest PTAB cases involving Glaxo Group New

Discover the latest PTAB cases involving Glaxo Group, highlighting their recent legal challenges and patent disputes.

Top competitors of Glaxo Group

Top competitors of Glaxo Group based on patent oppositions.